Episode 324: AAO 2021 Meeting Recap/Highlights

Drs. Shriji Patel, Basil Williams, and Yoshihiro Yonekawa join the podcast to discuss some of their favorite highlights from this the 2021 American Academy of Ophthalmology Annual Meeting, including a discussion of subretinal gene therapy for macular degeneration, the safety of brolucizumab, vitreoretinal surgical fellowship standardization, and more.

Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Allergan, Dorc, Genentech, and Regeneron. Dr. Yonekawa is a consultant for Alcon. Dr. Williams is a consultant for Allergan. Dr. Patel has no financial disclosures.

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi